House Patent Reform Bill, HR 1249, still has the Administration’s and BIO’s support

Patently BIOtech

The White House, Office of Management and Budget, Office of Science and Technology Policy, and the United States Patent and Trademark Office have come out in support of HR 1249 and the Manager’s Amendment to the bill.  The only caveat mentioned is that “final legislative action [should] ensure that the US Patent and Trademark Office’s (USPTO’s) fee collections are made fully available to support the nation’s patent and trademark system.”

BIO also has come out in support of the bill stating that “BIO will continue to work with House and Senate leaders to ensure that final patent reform legislation is perfected to address any remaining concerns and enacted into law this year.”

Paten Reform is scheduled to go on the House floor today.  Here is a summary of the amendments.

Patently BIOtech  |  Email This Post  |  Printer Friendly
Tags: , , , , , ,

3 Responses to House Patent Reform Bill, HR 1249, still has the Administration’s and BIO’s support

  1. staff says:

    This bill is nothing less than a giveaway for banks and huge multinationals and an off shoring job killing nightmare for America.

    Just because they call it “reform” doesn’t mean it is. Even the leading patent expert in China has stated the bill will help them steal our inventions. Who are Obama and the supporters of this bill working for??

    Patent reform is a fraud on America. This bill will not do what they claim it will. What it will do is help large multinational corporations maintain their monopolies by robbing and killing their small entity and startup competitors (so it will do exactly what the large multinationals paid for) and with them the jobs they would have created. Yet small entities create the lion’s share of new jobs. According to recent studies by the Kauffman Foundation and economists at the U.S. Census Bureau, “startups aren’t everything when it comes to job growth. They’re the only thing.” This bill is a wholesale slaughter of US jobs. Those wishing to help in the fight to defeat this bill should contact us as below.

    Small entities and inventors have been given far too little voice on this bill when one considers that they rely far more heavily on the patent system than do large firms who can control their markets by their size alone. The smaller the firm, the more they rely on patents -especially startups and individual inventors.

    Please see http://truereform.piausa.org/ for a different/opposing view on patent reform.
    http://docs.piausa.org/

    • Thank you for your comment! BIO’s membership consists largely of small biotech companies with no products yet on the market and which rely heavily on the strength of their IP to raise the investment necessary to bring innovative new medical therapies and other products to market. We fully support patent reform which will enhance patent quality and the efficiency, objectivity, predictability and transparency of the nation’s patent system. The patent reform legislation which passed the Senate by a nearly unanimous vote (95-5) and the bill expected to be voted upon by the House of Representatives this week would do just that. You can read more about the beneficial aspects of the bill at http://www.biotech-now.org/public-policy/patently-biotech/2011/03/patent-reform-passes-the-senate-and-moves-to-the-house.

  2. Without an end to fee diversion, “patent reform” is a waste, or worse.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>